Frequency of low serum LH is associated with increased early pregnancy loss in IVF/ICSI cycles

被引:33
作者
Chen, Chin-Der [1 ]
Chiang, Yi-Ting [1 ]
Yang, Po-Kai [1 ]
Chen, Mei-Jou [1 ]
Chang, Chin-Hao [2 ]
Yang, Yu-Shih [1 ]
Chen, Shee-Uan [1 ]
机构
[1] Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei, Taiwan
[2] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan
关键词
early pregnancy loss; GnRH antagonist; LH concentration; IN-VITRO FERTILIZATION; RECOMBINANT LUTEINIZING-HORMONE; FOLLICLE-STIMULATING-HORMONE; HUMAN CHORIONIC-GONADOTROPIN; GNRH ANTAGONIST PROTOCOL; HIGHLY PURIFIED HMG; OVARIAN STIMULATION; OOCYTE MATURATION; GROWTH-FACTOR; WOMEN;
D O I
10.1016/j.rbmo.2016.07.001
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The role of LH during ovarian stimulation remains uncertain. Previous studies defined the low LH group using a single LH measurement on a predefined day of stimulation possibly not reflecting the entire follicular phase. This study retrospectively collected data from 619 IVF/ICSI cycles with GnRH antagonist and recombinant FSH. The low LH group was defined as LH concentration <= 0.8 mIU/ml at any time during the cycle. Pregnancy results were compared between patients with one episode of low LH or more than two episodes of low LH (study group) and those without low LH (control group). There was no difference in fertilization rates between the two groups (67.5 +/- 1.7% versus 68.8 +/- 1.0%, respectively). The implantation rates (20.4% versus 25.2%), clinical pregnancy rates (43.9% versus 45.2%) and live-birth rates (LBR) (23.7% versus 30.4%) appeared lower in the study group, but the differences were not significant. In the study group, there were significantly increased early pregnancy loss rates (31.1% versus 16.3%, P = 0.012). The odds of early pregnancy loss increases by 1.55 fold for increased episodes of low serum LH (P = 0.029). Whether the adverse outcome is due to impaired oocyte quality or an endometrial component deserves further investigation. (C) 2016 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:449 / 457
页数:9
相关论文
共 39 条
  • [1] Gonadotrophin-releasing hormone antagonists for assisted reproductive technology
    Al-Inany, Hesham G.
    Youssef, Mohamed A. F. M.
    Aboulghar, Mohamed
    Broekmans, Frank
    Sterrenburg, Monique
    Smit, Janine
    Abou-Setta, Ahmed M.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (05):
  • [2] Randomized trial comparing luteinizing hormone supplementation timing strategies in older women undergoing ovarian stimulation
    Behre, Hermann M.
    Howles, Colin M.
    Longobardi, Salvatore
    [J]. REPRODUCTIVE BIOMEDICINE ONLINE, 2015, 31 (03) : 339 - 346
  • [3] In vitro maturation of human germinal vesicle-stage oocytes: role of epidermal growth factor-like growth factors in the culture medium
    Ben-Ami, I.
    Komsky, A.
    Bern, O.
    Kasterstein, E.
    Komarovsky, D.
    Ron-El, R.
    [J]. HUMAN REPRODUCTION, 2011, 26 (01) : 76 - 81
  • [4] Highly purified hMG versus recombinant FSH in ovarian hyperstimulation with GnRH antagonists - a randomized study
    Bosch, E.
    Vidal, C.
    Labarta, E.
    Simon, C.
    Remohi, J.
    Pellicer, A.
    [J]. HUMAN REPRODUCTION, 2008, 23 (10) : 2346 - 2351
  • [5] Impact of luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles: an age-adjusted analysis
    Bosch, Ernesto
    Labarta, Elena
    Crespo, Juana
    Simon, Carlos
    Remohi, Jose
    Pellicer, Antonio
    [J]. FERTILITY AND STERILITY, 2011, 95 (03) : 1031 - 1036
  • [6] Novel role for anti-Mullerian hormone in the regulation of GnRH neuron excitability and hormone secretion
    Cimino, Irene
    Casoni, Filippo
    Liu, Xinhuai
    Messina, Andrea
    Parkash, Jyoti
    Jamin, Soazik P.
    Catteau-Jonard, Sophie
    Collier, Francis
    Baroncini, Marc
    Dewailly, Didier
    Pigny, Pascal
    Prescott, Mel
    Campbell, Rebecca
    Herbison, Allan E.
    Prevot, Vincent
    Giacobini, Paolo
    [J]. NATURE COMMUNICATIONS, 2016, 7
  • [7] Urinary hMG versus recombinant FSH for controlled ovarian hyperstimulation following an agonist long down-regulation protocol in IVF or ICSI treatment: a systematic review and meta-analysis
    Coomarasamy, Arri
    Afnan, Masoud
    Cheema, Deepti
    van der Veen, Fulco
    Bossuyt, Patrick M. M.
    van Wely, Madelon
    [J]. HUMAN REPRODUCTION, 2008, 23 (02) : 310 - 315
  • [8] Follicular growth and oocyte maturation in GnRH agonist and antagonist protocols for in vitro fertilisation and embryo transfer
    Depalo, Raffaella
    Lorusso, Filomenamila
    Palmisano, Marcella
    Bassi, Emma
    Totaro, Ilaria
    Vacca, Margherita
    Trerotoli, Paolo
    Masciandaro, Paola
    Selvaggi, Luigi
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2009, 25 (05) : 328 - 334
  • [9] A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer
    Devroey, Paul
    Pellicer, Antonio
    Andersen, Anders Nyboe
    Arce, Joan-Carles
    [J]. FERTILITY AND STERILITY, 2012, 97 (03) : 561 - 571
  • [10] LH concentrations do not correlate with pregnancy in rFSH/GnRH antagonist cycles
    Doody, Kevin
    Devroey, Paul
    Gordon, Keith
    Witjes, Han
    Mannaerts, Bernadette
    [J]. REPRODUCTIVE BIOMEDICINE ONLINE, 2010, 20 (04) : 565 - 567